Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib and Laser Treatment for Diabetic Macular Edema
NCT00050479Phase 3Completed
- Sponsor
- National Eye Institute
- Start
- Dec 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic macular edema (DME) comparing Celecoxib with Placebo (2 arms). Primary endpoint: Change in Visual Acuity of 15 Letters or More at 3 years. Started Dec 2002; status: completed.
02
Drugs
celecoxib
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00050479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00050479.